Back to search
Pharmacogenomic Testing
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacogenomic Testing trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacogenomic Testing trials you may qualify forThis project addresses the problem of adverse drug reactions in the three most frequently prescribed therapeutic classes of drugs in children: antibiotics, anal…
To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the dis…
The purpose of this research study is to explore whether genetic testing can offer a personalized and timely approach to assist physicians in making more inform…
The purpose of this trial is to better understand how the beta-blocker metoprolol works in people with Heart Failure with Reduced Ejection Fraction (HFrEF) acco…
Statins are the most cost-effective medications to lower cholesterol and cardiovascular disease (CVD) risk. However, many patients at high-risk for CVD do not a…
The goal of this trial is to learn if a machine learning (ML) model can help optimize drug therapy in the pediatric population. The main question\[s\] it aims t…
Doctors leading this study hope to find out if giving study participants' genetic information to cancer care providers will help personalize chemotherapy dosing…
The goal of this prospective, randomized clinical trial is to learn whether pharmacogenomic (PGx)-guided comprehensive medication management delivered by pharma…